{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:43:44Z","timestamp":1783539824195,"version":"3.55.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,15]]},"DOI":"10.1093\/ecco-jcc\/jjy110","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T15:29:58Z","timestamp":1534519798000},"page":"1261-1269","source":"Crossref","is-referenced-by-count":11,"title":["A Global Survey of Gastroenterologists\u2019 Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas"],"prefix":"10.1093","volume":"12","author":[{"given":"Webber","family":"Chan","sequence":"first","affiliation":[{"name":"Gastroenterology and Liver Services, Sydney Local Health District, Concord Hospital, Sydney, Australia"},{"name":"Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang Hock","family":"Shim","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Chien","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Diseases, Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Asia\u2013Pacific Crohn\u2019s and Colitis Epidemiologic Study (ACCESS) Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Liu","sequence":"additional","affiliation":[{"name":"Gastroenterology and Liver Services, Sydney Local Health District, Concord Hospital, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Inglis","sequence":"additional","affiliation":[{"name":"Gastroenterology and Liver Services, Sydney Local Health District, Concord Hospital, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Greveson","sequence":"additional","affiliation":[{"name":"Royal Free Hospital NHS Foundation Trust Centre of Gastroenterology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Baraty","sequence":"additional","affiliation":[{"name":"Gastroenterology and Liver Services, Sydney Local Health District, Concord Hospital, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Haifer","sequence":"additional","affiliation":[{"name":"Gastroenterology and Liver Services, Sydney Local Health District, Concord Hospital, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert W L","family":"Leong","sequence":"additional","affiliation":[{"name":"Gastroenterology and Liver Services, Sydney Local Health District, Concord Hospital, Sydney, Australia"},{"name":"Faculty of Medicine, The University of New South Wales, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"key":"key\n\t\t\t\t2018111502460729900_CIT0001","first-page":"3","article-title":"Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn\u2019s disease and ulcerative colitis","volume":"45","author":"Mao","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0002","first-page":"1291","article-title":"Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn\u2019s disease and ulcerative colitis controlled trials","volume":"45","author":"Cholapranee","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0003","first-page":"443","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0004","first-page":"1834","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0005","first-page":"835","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0006","first-page":"657","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a Cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0007","first-page":"191","article-title":"Travelers\u2019 thrombosis","volume":"85","author":"Johnston","year":"2014","journal-title":"Aviat Space Environ Med"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0008","author":"World Health Organisation"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0009","first-page":"547","article-title":"Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials","volume":"46","author":"Lorenzetti","year":"2014","journal-title":"Ann Med"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0010","first-page":"20","article-title":"Asian Organization for Crohn\u2019s and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment","volume":"33","author":"Park","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0011","author":"Centers for Disease Control and Prevention"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0012","first-page":"e195S","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0013","first-page":"57","article-title":"Guidelines for the prevention and treatment of travelers\u2019 diarrhea: a graded expert panel report","volume":"24","author":"Riddle","year":"2017","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0014","first-page":"60","article-title":"Travel health and pretravel preparation in the patient with inflammatory bowel disease","volume":"7","author":"Greveson","year":"2016","journal-title":"Frontline Gastroenterol"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0015","first-page":"160","article-title":"Travel-associated health risks for patients with inflammatory bowel disease","volume":"10","author":"Ben-Horin","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0016","first-page":"291","article-title":"Risk of tuberculosis with anti-tumor necrosis factor-\u03b1 therapy: substantially higher number of patients at risk in Asia","volume":"17","author":"Navarra","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0017","first-page":"2499","article-title":"Treatment of ulcerative colitis with a humanized antibody to the \u03b14\u03b27 integrin","volume":"352","author":"Feagan","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0018","first-page":"3","article-title":"Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease","volume":"46","author":"Bye","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0019","first-page":"1383","article-title":"Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0020","first-page":"30","article-title":"Asian Organization for Crohn\u2019s and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management","volume":"33","author":"Park","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0021","first-page":"447","article-title":"Interferon-gamma release assays for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"194","author":"Lu","year":"2016","journal-title":"Lung"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0022","first-page":"64","article-title":"Effect of immunosuppressive therapy on interferon \u03b3 release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"71","author":"Wong","year":"2016","journal-title":"Thorax"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0023","first-page":"462","article-title":"Vaccination and screening for infections in patients with inflammatory bowel disease: a survey of Australian gastroenterologists","volume":"41","author":"Gupta","year":"2011","journal-title":"Intern Med J"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0024","first-page":"2536","article-title":"Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge","volume":"17","author":"Wasan","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0025","first-page":"34","article-title":"Inadequate knowledge of immunization guidelines: a missed opportunity for preventing infection in immunocompromised IBD patients","volume":"18","author":"Yeung","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018111502460729900_CIT0026","first-page":"S531","article-title":"Looking for evidence that personal hygiene precautions prevent traveler\u2019s diarrhea","volume":"41","author":"Shlim","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/12\/11\/1261\/26571647\/jjy110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T02:58:43Z","timestamp":1542250723000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/11\/1261\/5095284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,9,11]]},"published-print":{"date-parts":[[2018,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy110","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,9,11]]}}}